<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 57-year-old female developed <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) that terminated as a biphenotypic <z:hpo ids='HP_0001909'>leukemia</z:hpo> after exposure to chemoradiotherapy </plain></SENT>
<SENT sid="1" pm="."><plain>Double staining of blast cells, using monoclonal antibodies specific for myeloid and lymphoid lineage, demonstrated that one-third of the leukemic cells simultaneously expressed the E rosette-associated antigen (OKT11) and myeloid-associated antigen (MY7) </plain></SENT>
<SENT sid="2" pm="."><plain>This finding suggests the possibility that some cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> are clonal disorders that arise in a pluripotent stem cell that can also differentiate to T cell lineage </plain></SENT>
</text></document>